Implantable Glucose Sensor Global Market Report 2025
상품코드:1889484
리서치사:The Business Research Company
발행일:On Demand Report
페이지 정보:영문 250 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
세계의 이식형 혈당 센서 시장 규모는 최근 급속히 확대되고 있습니다. 2024년 70억 9,000만 달러에서 2025년에는 81억 4,000만 달러로, CAGR 14.9%로 성장이 전망되고 있습니다. 지난 몇 년간 성장 요인으로는 당뇨병 환자 증가, 지속적인 혈당 모니터링에 대한 수요 증가, 당뇨병 합병증에 대한 환자 의식 증가, 의료 인프라 확대, 상환 정책 개선 등이 있습니다.
이식형 혈당 센서 시장 규모는 향후 수년간 급속한 성장이 예상됩니다. 2029년까지 140억 3,000만 달러에 달하고, CAGR은 14.6%가 될 전망입니다. 예측기간의 성장은 당뇨병 발병률의 상승, 저침습형 혈당 센서에 대한 수요 증가, 디지털 헬스 기술의 통합 확대, 구독형 비즈니스 모델의 보급, 신흥 시장 진출, 규제면 지원 강화 등에 기인한다고 생각됩니다. 예측 기간 동안 예상되는 주요 동향은 센서 수명 연장 기술, 생체적합성 재료 개발, 무선 연결 기술 혁신, 교정 정밀도 향상, 임베디드 아키텍처에 대한 지속적인 연구 개발 등을 포함합니다.
당뇨병의 유병률 상승은 향후 수년간 이식형 혈당 센서 시장의 성장을 이끌 것으로 예측됩니다. 당뇨병은 신체가 혈당을 적절히 조절할 수 없는 만성 질환입니다. 그 유병률 증가는 주로 신체 활동의 감소와 높은 칼로리 식품의 섭취 증가 등 건강에 해로운 생활 습관에 기인하고 있으며, 이들은 2형 당뇨병 발병 위험을 높입니다. 이식형 혈당 센서는 혈당 수치의 지속적이고 장기적인 모니터링을 제공하여 당뇨병 관리를 지원하고 엄격한 혈당 조절이 필요한 환자에게 특히 유용합니다. 실시간 데이터 및 경고 기능은 빈번히 손가락을 찔러 검사할 필요성을 줄이고 환자의 편의성을 높이고 건강 상태 개선에 기여합니다. 예를 들어, 영국 국민보건서비스(NHS)에 따르면 2023년에는 일반 개업의에 등록된 3,615,330명이 비당뇨병성 고혈당 또는 전당뇨병으로 진단되어 2022년 306만 5,825건에서 18% 증가를 보였습니다. 그 결과, 당뇨병의 유병률 증가가 이식형 혈당 센서 시장의 확대를 촉진하고 있습니다.
이식형 혈당 센서 시장의 주요 기업은 환자의 편의성과 건강 상태 개선, 빈번한 장치 관리의 필요성을 줄이기 위해 장기 이식형 센서와 같은 첨단 장치 개발에 주력하고 있습니다. 장기 이식형 센서는 빈번한 교체가 필요한 단기 센서와 달리 피하에 내장되는 의료기기로, 장기간에 걸쳐 조직 간 액체의 혈당 농도를 지속적으로 측정합니다. 예를 들어, 2024년 9월에는 미국에 본사를 둔 의료 기술 기업인 Senseonics Holdings Inc.가 1형 또는 2형 당뇨병을 앓고 있는 18세 이상의 개인을 위한 'Eversense 365' 연속 혈당 모니터링 시스템에 대해 FDA 승인을 받았습니다. 이 시스템은 최대 365일간 지속되는 완전 내장형 센서를 특징으로 하며, 지속적인 혈당 측정과 고혈당 및 저혈당시 경보를 제공합니다. 또한 모바일 앱 및 클라우드 플랫폼과 협력하여 환자와 의료 종사자가 원격으로 혈당 수치의 동향을 모니터링하고 적절한 치료 결정을 내릴 수 있습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 이식형 혈당 센서 시장 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 이용 산업의 분석
세계의 이식형 혈당 센서 시장 : 성장률 분석
세계의 이식형 혈당 센서 시장 실적 : 규모와 성장, 2019-2024년
세계의 이식형 혈당 센서 시장 예측 : 규모와 성장, 2024-2029년, 2034F
세계의 이식형 혈당 센서 : 총 시장 규모(TAM)
제6장 시장 세분화
세계의 이식형 포도당 센서 시장 : 제품 유형별, 분석과 예측, 2019-2024년, 2024-2029F, 2034F
장기 이식형 센서
단기 이식형 센서
세계의 이식형 포도당 센서 시장 : 기술별, 분석과 예측, 2019-2024년, 2024-2029F, 2034F
효소형
비효소형
세계의 이식형 포도당 센서 시장 : 용도별, 분석과 예측, 2019-2024년, 2024-2029F, 2034F
1형 당뇨병
2형 당뇨병
임신성 당뇨
세계의 이식형 혈당 센서 시장 : 최종 사용자별, 분석과 예측, 2019-2024년, 2024-2029F, 2034F
병원
클리닉
재택치료 환경
기타 최종 사용자
세계의 이식형 혈당 센서 시장 : 장기 이식형 센서 유형별, 분석과 예측, 2019-2024년, 2024-2029F, 2034F
효소 기반
전기화학
형광 기반
광학식
세계의 이식형 혈당 센서 시장 : 단기 이식형 센서 유형별, 분석과 예측, 2019-2024년, 2024-2029F, 2034F
저침습
마이크로니들 기반
생체 적합성 하이드로겔 기반
일회용
제7장 지역별/국가별 분석
세계의 이식형 혈당 센서 시장 : 지역별, 분석과 예측, 2019-2024년, 2024-2029F, 2034F
세계의 이식형 혈당 센서 시장 : 국가별, 분석과 예측, 2019-2024년, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 프로파일
이식형 혈당 센서 시장 : 경쟁 구도
이식형 혈당 센서 시장 : 기업 프로파일
Cirtec Medical Corporation : 개요, 제품 및 서비스, 전략 및 재무 분석
Biolinq Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
Senseonics Holdings Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
Biorasis Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
GlucoTrack Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
GluSense Ltd.
GlucoTech Ltd.
Integrated Medical Sensors Inc.
World Precision Instruments
Indigo Diabetes NV
GlySens Incorporated
Profusa Inc.
Lifecare ASA
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
이식형 혈당 센서 시장(2029년) : 새로운 기회를 제공하는 국가
이식형 혈당 센서 시장(2029년) : 새로운 기회를 제공하는 부문
이식형 혈당 센서 시장(2029년) : 성장 전략
시장 동향에 기초한 전략
경쟁 전략
제36장 부록
JHS
영문 목차
영문목차
An implantable glucose sensor is a small medical device placed beneath the skin to continuously measure the body's glucose levels and transmit the readings to an external monitor or smart device. It helps individuals manage diabetes more easily by offering real-time data without the need for frequent finger-prick tests. The device functions inside the body for an extended duration, providing a more convenient and consistent method for monitoring blood sugar.
The key product types of implantable glucose sensors include long-term implantable sensors and short-term implantable sensors. Long-term implantable sensors are glucose monitoring devices designed to remain under the skin for an extended period-typically weeks to months-to continuously measure blood glucose levels. These sensors utilize technologies such as enzymatic and non-enzymatic methods and are used for conditions such as type 1 diabetes, type 2 diabetes, and gestational diabetes. They serve end users including hospitals, clinics, home-care settings, and others.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers' margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.
The implantable glucose sensor market research report is one of a series of new reports from The Business Research Company that provides implantable glucose sensor market statistics, including implantable glucose sensor industry global market size, regional shares, competitors with a implantable glucose sensor market share, detailed implantable glucose sensor market segments, market trends and opportunities, and any further data you may need to thrive in the implantable glucose sensor industry. This implantable glucose sensor market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The implantable glucose sensor market size has grown rapidly in recent years. It will grow from $7.09 billion in 2024 to $8.14 billion in 2025 at a compound annual growth rate (CAGR) of 14.9%. Growth in the historic period can be attributed to the increasing prevalence of diabetes, rising demand for continuous glucose monitoring, growing patient awareness of diabetes complications, expanding healthcare infrastructure, and improving reimbursement policies.
The implantable glucose sensor market size is expected to see rapid growth in the next few years. It will grow to $14.03 billion in 2029 at a compound annual growth rate (CAGR) of 14.6%. Growth in the forecast period can be linked to the rising incidence of diabetes, growing demand for minimally invasive glucose sensors, expanded integration of digital health technologies, increased use of subscription-based business models, expansion into emerging markets, and rising regulatory support. Major trends expected during the forecast period include technological advancements in sensor longevity, development of biocompatible materials, innovations in wireless connectivity, improved calibration accuracy, and ongoing research and development in implantable architectures.
The rising prevalence of diabetes is expected to drive the growth of the implantable glucose sensor market in the coming years. Diabetes is a chronic condition in which the body cannot properly regulate blood sugar or glucose levels. Its prevalence is increasing largely due to unhealthy lifestyle habits, such as reduced physical activity and higher consumption of calorie-dense foods, which raise the risk of developing type 2 diabetes. Implantable glucose sensors support diabetes management by providing continuous, long-term monitoring of blood glucose levels, making them especially useful for patients who require tight glucose control. By offering real-time data and alerts, these devices reduce the need for frequent finger-prick tests, enhancing patient convenience and improving overall health outcomes. For example, according to the UK's National Health Service, in 2023, 3,615,330 individuals registered with a general practitioner were diagnosed with non-diabetic hyperglycemia or pre-diabetes, representing an 18% increase from 3,065,825 cases in 2022. As a result, the growing prevalence of diabetes is fueling the expansion of the implantable glucose sensor market.
Major players in the implantable glucose sensor market are focusing on developing advanced devices, such as long-term implantable sensors, to improve patient convenience, health outcomes, and reduce the need for frequent device management. Long-term implantable sensors are medical devices placed under the skin to continuously measure glucose levels in the interstitial fluid over extended periods, unlike short-term sensors that require frequent replacement. For instance, in September 2024, Senseonics Holdings Inc., a US-based medical technology company, received FDA approval for the Eversense 365 continuous glucose monitoring system for individuals aged 18 and older with Type 1 or Type 2 diabetes. The system features a fully implantable sensor that lasts up to 365 days, providing continuous glucose readings and alerts for high and low glucose levels. It also connects to a mobile app and cloud platform, allowing patients and healthcare providers to remotely monitor glucose trends and make informed treatment decisions.
In May 2024, Senseonics Holdings Inc. partnered with Mercy to expand the clinical adoption of the Eversense continuous glucose monitoring system across Mercy's network. This collaboration enables patients to benefit from long-duration implantable glucose monitoring, supported by remote patient monitoring and streamlined endocrinology workflows. Mercy is a US-based integrated healthcare organization offering hospital care, outpatient services, virtual care, and chronic disease management programs.
Major companies operating in the implantable glucose sensor market are Cirtec Medical Corporation, Biolinq Inc., Senseonics Holdings Inc., Biorasis Inc., GlucoTrack Inc., GluSense Ltd., GlucoTech Ltd., Integrated Medical Sensors Inc., World Precision Instruments, Indigo Diabetes N.V., GlySens Incorporated, Profusa Inc., Lifecare ASA
North America was the largest region in the implantable glucose sensor market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in implantable glucose sensor report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the implantable glucose sensor market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The implantable glucose sensor market consists of sales of implantable glucose monitoring devices, biocompatible sensor probes, external data transmitters, wearable reader units, calibration accessories, and adhesive patches. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Implantable Glucose Sensor Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on implantable glucose sensor market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for implantable glucose sensor ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The implantable glucose sensor market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
3. Implantable Glucose Sensor Market Trends And Strategies
4. Implantable Glucose Sensor Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global Implantable Glucose Sensor Growth Analysis And Strategic Analysis Framework
5.1. Global Implantable Glucose Sensor PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Implantable Glucose Sensor Market Growth Rate Analysis
5.4. Global Implantable Glucose Sensor Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Implantable Glucose Sensor Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Implantable Glucose Sensor Total Addressable Market (TAM)
6. Implantable Glucose Sensor Market Segmentation
6.1. Global Implantable Glucose Sensor Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Long-term Implantable Sensors
Short-term Implantable Sensors
6.2. Global Implantable Glucose Sensor Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Enzymatic
Non-Enzymatic
6.3. Global Implantable Glucose Sensor Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Type 1 Diabetes
Type 2 Diabetes
Gestational Diabetes
6.4. Global Implantable Glucose Sensor Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Clinics
Homecare Settings
Other End-Users
6.5. Global Implantable Glucose Sensor Market, Sub-Segmentation Of Long-Term Implantable Sensors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Enzyme Based
Electrochemical
Fluorescence Based
Optical
6.6. Global Implantable Glucose Sensor Market, Sub-Segmentation Of Short-Term Implantable Sensors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Minimally Invasive
Microneedle Based
Biocompatible Hydrogel-Based
Disposable
7. Implantable Glucose Sensor Market Regional And Country Analysis
7.1. Global Implantable Glucose Sensor Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Implantable Glucose Sensor Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
